Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ArthroCare Announces Live Webcast of Coblation Tonsillectomy from Georgetown University Hospital.


Business Editors/Health/Medical Writers

SUNNYVALE, Calif.--(BUSINESS WIRE)--Feb. 18, 2004

ArthroCare(R) Corp. (Nasdaq:ARTC ARTC Arthrocare Corp (stock symbol)
ARTC Australian Rail Track Corporation
ARTC Air Route Traffic Control
ARTC Association de la Recherche Theatrale au Canada
ARTC Andean Root and Tuber Crops
), a multi-business medical device company that develops products based on its patented Coblation(R) technology, announced today that Dr. Earl Harley, associate professor and attending pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children.

pe·di·at·ric
adj.
Of or relating to pediatrics.
 otolaryngologist at Georgetown University Hospital Coordinates:

Georgetown University Hospital was founded in 1898 as part of Georgetown University, a Catholic, Jesuit University in the Georgetown neighborhood of
, will perform a Coblation tonsillectomy tonsillectomy /ton·sil·lec·to·my/ (ton?si-lek´tah-me) excision of a tonsil.

ton·sil·lec·to·my
n.
Surgical removal of tonsils or a tonsil.
 during a live Webcast designed to showcase the improved clinical outcomes that result from this advanced procedure.

Event Details

-- Date: Mon., Feb. 23, 2004

-- Time: 12:00 p.m. (noon) ET / 9:00 a.m. PT / 17:00 UTC (Coordinated Universal Time, Temps Universel Coordonné) The international time standard (formerly Greenwich Mean Time, or GMT). Zero hours UTC is midnight in Greenwich, England, which is located at 0 degrees longitude.  

-- Webcast Link: http://www.or-live.com/georgetownhospital/1149

A camera crew will provide complete access to the operating theater during the Webcast and live audio will be featured from within the operating room operating room
n. Abbr. OR
A room equipped for performing surgical operations.
. While Dr. Harley performs the surgery, Dr. Norman Sanders, medical director for ArthroCare, will provide commentary on the procedure and handle email questions from viewers.

Coblation Tonsillectomy Background

Derived from the words "controlled ablation," Coblation uses radiofrequency energy to convert saline solution saline solution
n.
A solution of any salt, usually an isotonic sodium chloride solution. Also called salt solution.


Saline solution
A solution of sterile water and salt used in a variety of medical procedures.
 into a precisely focused plasma. The energized particles in this plasma have sufficient energy to break molecular bonds, excising or dissolving soft tissue at relatively low temperatures (typically 40 degrees C to 70 degrees C), thereby preserving the integrity of surrounding healthy tissue.

The U.S. Food and Drug Administration (FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
) cleared Coblation for use in tonsillectomy and adenoidectomy Tonsillectomy and Adenoidectomy Definition

Tonsillectomy and adenoidectomy (T & A) are surgical procedures to remove the tonsils from the back of the mouth or adenoids from the back of the nasal cavity—both are are part of the lymphatic
 procedures in July 2001. Since the first Coblation tonsillectomy was performed in January 2000, physicians have performed more than 80,000 procedures worldwide.

About ArthroCare

ArthroCare Corp. (www.arthrocare.com), headquartered in Sunnyvale, Calif., is a multi-business medical device company that develops, manufactures and markets minimally invasive soft tissue surgical products based on its patented Coblation technology. Coblation uses low-temperature radiofrequency energy to gently and precisely dissolve rather than burn soft tissue, minimizing damage to healthy tissue. ArthroCare targets a multi-billion dollar market opportunity across several medical specialties, significantly improving surgical procedures and enabling new, minimally invasive procedures. ArthroCare's Coblation-based devices have been used in more than 2.5 million surgical procedures worldwide. The company has developed and marketed Coblation-based products for arthroscopic, spine/neurologic, ear, nose and throat, cosmetic, urologic, gynecologic gynecologic /gy·ne·co·log·ic/ (gi?ne-) (jin?e-kah-loj´ik) pertaining to the female reproductive tract or to gynecology.  and laparoscopic/general surgical procedures, and continues research in other areas.

Safe Harbor Statements

Except for historical information, this press release includes forward-looking statements. These statements include, but are not limited to, the company's stated business outlook for fiscal 2003, continued strength of the company's fundamental position, the strength of the company's technology, the company's belief that strategic moves will enhance achievement of the company's long term potential, the potential and expected rate of growth of new businesses, continued success of product diversification efforts, and other statements that involve risks and uncertainties. These risks and uncertainties include, but are not limited to the uncertainty of success of the company's non-arthroscopic products, competitive risk, uncertainty of the success of strategic business alliances, uncertainty over reimbursement, need for governmental clearances or approvals before selling products, and the uncertainty of protecting the company's patent position. These and other risks and uncertainties are detailed from time to time in the company's Securities and Exchange Commission filings, including ArthroCare's Form 10-K for the year ended December 31, 2002 and the 10-Q for the quarter ended Sept. 30, 2003. Forward-looking statements are indicated by words or phrases such as "anticipates," "estimates," "projects," "believes," "intends," "expects," and similar words and phrases Words and Phrases®

A multivolume set of law books published by West Group containing thousands of judicial definitions of words and phrases, arranged alphabetically, from 1658 to the present.
. Actual results may differ materially from management expectations.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 18, 2004
Words:570
Previous Article:Bouygues Leverages Array Networks to Provide Unparalleled Secure Global Access.
Next Article:BA Venture Partners Seizes Opportunities in Growing Consumer Electronics Market.
Topics:



Related Articles
ARTHROCARE'S COBLATION SYSTEM TO BE USED FOR BRAIN SURGERY.
ArthroCare Announces Expanded FDA Clearance for Coblation Assisted Tonsillectomy; New Device Allows More Flexibility in Technique.
ArthroCare Introduces Laparoscopic and General Surgery Product Set; Third Quarter Results Meet Expectations.
ArthroCare to Announce First Quarter Financial Results April 18.
ArthroCare to Present At Bear Stearns 15th Annual Healthcare Conference; Presentation September 18 to be Webcast Live.
Newly Published Study Shows Coblation Tonsillectomy to be Less Painful, Fast-Healing Procedure.
ArthroCare to Present At Goldman, Sachs Annual Global Healthcare Conference; Presentation June 13 to be Webcast Live.
ArthroCare's Third Quarter Product Revenues Rise 34 Percent to $28.6 Million; Net Income Grows 225 Percent Year-over-Year with EPS of $0.10.
ArthroCare Announces Management Team Changes in Spine and ENT Business Units.
ArthroCare Announces Live Webcast of Coblation-Based ENT Surgical Procedures from Blackburn Royal Infirmary.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles